Abstract
We report a patient with headaches meeting the criteria of chronic paroxysmal hemicrania, as defined by the International Headache Society classification. Headaches were fully responsive to indomethacin during the first 3 months of treatment but recurred when daily doses were lowered. Investigations revealed a macroprolactinoma. Headaches stopped after cabergoline treatment. This report further suggests that patients with paroxysmal hemicrania should be investigated for pituitary abnormalities.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antineoplastic Agents / administration & dosage
-
Cabergoline
-
Causality
-
Diagnosis, Differential
-
Dopamine Agonists / administration & dosage
-
Ergolines / administration & dosage
-
Female
-
Humans
-
Indomethacin / administration & dosage
-
Paroxysmal Hemicrania / diagnosis*
-
Paroxysmal Hemicrania / drug therapy
-
Paroxysmal Hemicrania / etiology*
-
Prolactinoma / complications*
-
Prolactinoma / diagnosis*
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antineoplastic Agents
-
Dopamine Agonists
-
Ergolines
-
Cabergoline
-
Indomethacin